MyFinsight
Home
Blog
About
Back
Cash Flow
Petros Pharmaceuticals, Inc. (PTPI)
Petros Pharmaceuticals, Inc. (PTPI)
source: myfinsight.com
Net increase
(decrease) in cash
-$863,855
(-123.92%↓ Y/Y)
Net cash used in
operating activities
-$863,855
(81.49%↑ Y/Y)
Employee stock-based
compensation
$117,906
(-23.62%↓ Y/Y)
Accrued expenses
$25,910
(-83.91%↓ Y/Y)
Net cash used in
operating activities -...
-$863,855
(67.72%↑ Y/Y)
Canceled cashflow
$143,816
Operating loss from
continuing operations
-$955,625
Accounts payable
-$36,022
(-117.51%↓ Y/Y)
Prepaid expenses and
other current assets
$15,124
(-79.69%↓ Y/Y)
Change in fair value of
warrant liability
-$900
(99.99%↑ Y/Y)
Back